Back

CRDA

0.16%
NEUTRAL

Croda Appoints UBS as Joint Corporate Broker

Why we think this is neutral

The RNS announcement is a general corporate update on the appointment of a new joint corporate broker, UBS, which does not contain any specific financial or operational information. As such, it is a neutral update that does not significantly impact the company's performance or outlook.

Key Points

  • Croda has appointed UBS as a joint corporate broker

Summary

The specialty chemicals company has appointed UBS as a joint corporate broker, working alongside Morgan Stanley.

Croda International Plc has appointed UBS as a joint corporate broker, to work alongside Morgan Stanley, with immediate effect. The company did not provide any further details on the reasons for the appointment or its potential impact.

GENERAL UPDATE